Hepion Pharmaceuticals (HEPA) Earnings Date & Reports

A.I. Advisor

published Earnings

HEPA is expected to report earnings to rise 61.11% to -290 cents per share on May 16

Hepion Pharmaceuticals HEPA Stock Earnings Reports

Q1'23

Est.

$-2.90

Q4'22

Missed

by $1.68

Q3'22

Beat

by $0.06

Q2'22

Missed

by $4.94

Q1'22

Est.

$-0.09

The last earnings report on March 01 showed earnings per share of -179 cents, missing the estimate of -11 cents. With 5.45K shares outstanding, the current market capitalization sits at 3.94M.

View a ticker or compare two or three

Compare

HEPA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For HEPA
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a pharmaceutical company, which engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

399 Thornall Street

Phone

+1 732 902-4000

Employees

Web

https://www.hepionpharma.com